The Improvement of first Iteration Log Periodic Fractal Koch Antenna with Slot Implementation

In this paper, a slotted is introduced at each of the radiating elements on the 1st iteration log periodic fractal Koch antenna (LPFKA). The antenna is designed to testify the appropriate performance at UHF Digital television which operates from 4.0 GHz to 1.0 GHz. The dimension of the conventional 0th iteration LPKFA is successfully reduced by 17% with the implementation of slotted. The results show a good agreement with a stable radiation pattern across the operating bandwidth, stable gain more than 5 dBi and reflection coefficient of below -10 dB over the desired frequency range

Agarwood oil quality classifier using machine learning

Agarwood oil is known as one of the most expensive and precious oils being traded. It is widely used in traditional ceremonies and religious prayers. Its quality plays an important role on the market price that it can be traded. This paper proposes on a proper classification method of the agarwood oil quality using machine learning model k-nearest neighbour (k-NN). The chemical compounds of the agarwood oil from high and low quality are used to train and build the k-NN classifier model. Correlation reduce the dimension of the data before it is being fed into the model. The results show a very high accuracy (100%) model trained and can be used to classify the agarwood oil quality accurately. Keywords: agarwood oil; k-nearest neighbours; quality; machine learning

Frequency tuning varactor-loaded reconfigurable antenna for m-WiMAX and WLAN applications

A design approach for a microstrip patch antenna to achieve the reconfigurable dual-band operation with a tunable device is presented in this work. The approach uses a BB833 varactor diode in the middle of a slotted patch antenna which which is able to produce dual-band resonant frequencies. The reconfigurable antenna is designed and simulated in CST Microwave Studio® software and is later, fabricated on a FR-4 substrate with a dielectric constant, εr of 4.5, loss tangent, tan δ of 0.019 and thickness, h of 1.6 mm. By changing the DC voltages of the varactor diode, different capacitance values of the varactor diode are obtained which dictate the specific resonant frequencies. From the simulation results, the capacitance value of 0.5 pF with a bias voltage of 2.0 V is chosen as it produces the required dual-band resonant frequencies at 3.38 GHz and 5.37 GHz for desired applications in the m-WiMAX and WLAN bands

Frequency reconfiguration mechanism of a PIN diode on a reconfigurable antenna for LTE and WLAN Applications

Microstrip patch antennas are increasingly gaining popularity for usage in portable wireless system applications due to their light weight, low profile structure, low cost of production and robust nature. The patch is generally made of a conducting material such as copper or gold and can take any possible shapes, but rectangular shapes are generally used to simplify analysis and performance prediction. Microstrip patch antenna radiates due to the fringing fields between the patch edge and ground plane. In this work, a frequency reconfigurable antenna with a BAR63-02V Positive-Intrinsic-Negative (PIN) diode is designed, simulated and fabricated. The antenna operates at 2.686GHz for Long-Term Evolution (LTE2500) and 5.164GHz for Wireless Local Area Network (WLAN) applications. In the OFF state, the antenna operates at 5.302GHz, which is also suitable for WLAN application. The proposed antenna is fabricated on a FR-4 substrate with a relative dielectric constant, εr of 4.5, thickness, h of 1.6mm and loss tangent, tan δ of 0.019. The fabrication process is carried out at the Advanced Printed Circuit Board (PCB) Design Laboratory in UTHM

Design process and simulation testing of a shape memory alloy actuated robotic microgripper

Microgrippers are commonly used for micromanipulation of micro-objects with dimensions from 1 to 100 µm and attain features of reliable accuracy, low cost, wide jaw aperture and variable applied force. This paper studies the design process, simulation, and testing of a microgripper which can manipulate and assemble a platinum resistance temperature probe, made from a 25 µm diameter platinum wire, a 20 mm diameter tinned copper wire, and a printed circuit board type connector. Various microgripper structures and actuator types were researched and reviewed to determine the most suitable design for the required micromanipulation task. Operation tests using SolidWorks and ANSYS software were conducted to test a parallelogram structure with flexible single-notch hinges. The best suited material was found to be Aluminium alloy 7075-T6 as it was capable of producing a large jaw tip displacement of 0.7 mm without exceeding its tensile yield strength limit. A shape memory alloy was chosen as a choice of actuator to close the microgripper jaws. To ensure a repeatably accurate datum point, the final microgripper consisted of a fixed arm and a flexible arm. An optimisation process using ANSYS studied the hinge thickness and radius dimensions of the microgripper which improved its deflection whilst reducing the experienced stress

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Background: Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent plasma therapy in patients admitted to hospital with COVID-19. Methods: This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]) is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. The trial is underway at 177 NHS hospitals from across the UK. Eligible and consenting patients were randomly assigned (1:1) to receive either usual care alone (usual care group) or usual care plus high-titre convalescent plasma (convalescent plasma group). The primary outcome was 28-day mortality, analysed on an intention-to-treat basis. The trial is registered with ISRCTN, 50189673, and ClinicalTrials.gov, NCT04381936. Findings: Between May 28, 2020, and Jan 15, 2021, 11558 (71%) of 16287 patients enrolled in RECOVERY were eligible to receive convalescent plasma and were assigned to either the convalescent plasma group or the usual care group. There was no significant difference in 28-day mortality between the two groups: 1399 (24%) of 5795 patients in the convalescent plasma group and 1408 (24%) of 5763 patients in the usual care group died within 28 days (rate ratio 1·00, 95% CI 0·93–1·07; p=0·95). The 28-day mortality rate ratio was similar in all prespecified subgroups of patients, including in those patients without detectable SARS-CoV-2 antibodies at randomisation. Allocation to convalescent plasma had no significant effect on the proportion of patients discharged from hospital within 28 days (3832 [66%] patients in the convalescent plasma group vs 3822 [66%] patients in the usual care group; rate ratio 0·99, 95% CI 0·94–1·03; p=0·57). Among those not on invasive mechanical ventilation at randomisation, there was no significant difference in the proportion of patients meeting the composite endpoint of progression to invasive mechanical ventilation or death (1568 [29%] of 5493 patients in the convalescent plasma group vs 1568 [29%] of 5448 patients in the usual care group; rate ratio 0·99, 95% CI 0·93–1·05; p=0·79). Interpretation: In patients hospitalised with COVID-19, high-titre convalescent plasma did not improve survival or other prespecified clinical outcomes. Funding: UK Research and Innovation (Medical Research Council) and National Institute of Health Research

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Background: In this study, we aimed to evaluate the effects of tocilizumab in adult patients admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods: This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. Those trial participants with hypoxia (oxygen saturation <92% on air or requiring oxygen therapy) and evidence of systemic inflammation (C-reactive protein ≥75 mg/L) were eligible for random assignment in a 1:1 ratio to usual standard of care alone versus usual standard of care plus tocilizumab at a dose of 400 mg–800 mg (depending on weight) given intravenously. A second dose could be given 12–24 h later if the patient's condition had not improved. The primary outcome was 28-day mortality, assessed in the intention-to-treat population. The trial is registered with ISRCTN (50189673) and ClinicalTrials.gov (NCT04381936). Findings: Between April 23, 2020, and Jan 24, 2021, 4116 adults of 21 550 patients enrolled into the RECOVERY trial were included in the assessment of tocilizumab, including 3385 (82%) patients receiving systemic corticosteroids. Overall, 621 (31%) of the 2022 patients allocated tocilizumab and 729 (35%) of the 2094 patients allocated to usual care died within 28 days (rate ratio 0·85; 95% CI 0·76–0·94; p=0·0028). Consistent results were seen in all prespecified subgroups of patients, including those receiving systemic corticosteroids. Patients allocated to tocilizumab were more likely to be discharged from hospital within 28 days (57% vs 50%; rate ratio 1·22; 1·12–1·33; p<0·0001). Among those not receiving invasive mechanical ventilation at baseline, patients allocated tocilizumab were less likely to reach the composite endpoint of invasive mechanical ventilation or death (35% vs 42%; risk ratio 0·84; 95% CI 0·77–0·92; p<0·0001). Interpretation: In hospitalised COVID-19 patients with hypoxia and systemic inflammation, tocilizumab improved survival and other clinical outcomes. These benefits were seen regardless of the amount of respiratory support and were additional to the benefits of systemic corticosteroids. Funding: UK Research and Innovation (Medical Research Council) and National Institute of Health Research

PSSA pore-filled PVDF membranes by simultaneous electron beam irradiation: preparation and transport characteristics of protons and methanol

Polystyrene sulfonic acid (PSSA) pore-filled poly(vinylidene fluoride) (PVDF) membranes have been prepared using simultaneous electron irradiation method. Porous PVDF films were grafted by pre-swelling in styrene solution and subsequent irradiation with an electron beam (EB) under nitrogen atmosphere and at ambient temperature. The grafted films i.e. polystyrene (PS) pore-filled PVDF were subsequently sulfonated with a diluted mixture of chlorosufonic acid. The effects of the reaction parameters on the content of PS grafted in the pores of PVDF films were investigated. The chemical and morphological properties of the membranes in comparison with their un-grafted and grafted counterparts were studied by Fourier transform infrared spectroscopy (FTIR) and scanning electron microscopy (SEM). The transport properties of these membranes such as ionic conductivity and methanol permeability were evaluated and correlated with the content of PS grafted in the pores of the PVDF films. The PSSA pore-filled PVDF membranes with PS content in the pores of 40% and above showed superior performance characteristics compared to Nafion 117 membrane and therefore can be potential alternatives to improve the performance of direct methanol fuel cell (DMFC)